Correlation Between Checkpoint Therapeutics and Cocrystal Pharma

Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Checkpoint Therapeutics and Cocrystal Pharma, you can compare the effects of market volatilities on Checkpoint Therapeutics and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Cocrystal Pharma.

Diversification Opportunities for Checkpoint Therapeutics and Cocrystal Pharma

-0.01

Correlation Coefficient

Checkpoint Therapeutics  Cocrystal Pharma

Good diversification

The 3 months correlation between Checkpoint and Cocrystal is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Checkpoint Therapeutics and Cocrystal Pharma

Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 0.35 times more return on investment than Cocrystal Pharma. However, Checkpoint Therapeutics is 2.84 times less risky than Cocrystal Pharma. It trades about -0.12 of its potential returns per unit of risk. Cocrystal Pharma is currently generating about -0.07 per unit of risk. If you would invest  354.00  in Checkpoint Therapeutics on October 22, 2024 and sell it today you would lose (36.00) from holding Checkpoint Therapeutics or give up 10.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Checkpoint Therapeutics  vs.  Cocrystal Pharma

Checkpoint Therapeutics

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Checkpoint Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, Checkpoint Therapeutics may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Cocrystal Pharma

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Cocrystal Pharma are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental indicators, Cocrystal Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Checkpoint Therapeutics and Cocrystal Pharma

The main advantage of trading using opposite Checkpoint Therapeutics and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.

The idea behind Checkpoint Therapeutics and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.